throbber
One Luitpold Drive, PO Box 9001, Shirley, New York 11967
`(631) 924-4000 • (800) 645-1706 • Fax (631) 924-1731
`
`
`
`PRESS RELEASE
`
`
`
`
`FOR IMMEDIATE RELEASE
`June 17, 2005
`
`Contact:
`Contact Information:
`Walter Tozzi
`Director of Marketing
`American Regent, Inc.
`1-631-924-4000
`Venofer® (iron sucrose injection, USP) receives FDA approval for the
`Treatment of Iron Deficiency Anemia in Pre-Dialysis Patients
`
`Shirley, N.Y. - June 17, 2005: American Regent/Luitpold Pharmaceuticals announced today
`that the U.S. Food and Drug Administration (FDA) has approved Venofer® (iron sucrose
`injection, USP) for the treatment of iron deficiency anemia in Chronic Kidney Disease
`Patients Not on Dialysis.
`
`According to the National Kidney Foundation, 20 million Americans have Chronic Kidney
`Disease (CKD). Of these, approximately 8 million are considered to be Stages III and IV
`and many may require intravenous iron supplementation to treat iron deficiency anemia, a
`common complication of CKD. Patients with kidney failure suffer from a reduced ability to
`produce erythropoietin leading to impairment of new red blood cell production and
`eventually iron deficiency anemia. Iron is essential to effective hemoglobin and red blood
`cell production. Untreated depletion of iron stores leads to iron-deficient erythropoiesis and
`iron-deficiency anemia.
`
`First approved in 2000 for the treatment of iron deficiency anemia in patients undergoing
`hemodialysis on supplemental erythropoietin therapy, Venofer® received a positive
`national coverage decision by CMS in 2001 and has been assigned a specific HCPCS Code:
`J-1756 for that indication. Venofer®, currently the #1 prescribed IV iron, is the first and
`only non-dextran IV iron approved for use in the pre-dialysis population. Venofer® is now
`FDA approved at a higher dose of iron per single dose administration than any other IV
`iron.
`
`
`
`Pharmacosmos, Exh. 1058, p. 1
`
`

`
`
`
`
`
`In non-dialysis dependent CKD patients, Venofer® is administered to a total cumulative dose of
`1000mg over a 14 day period as a 200mg slow IV injection undiluted over 2 to 5 minutes on 5
`different occasions within the 14 day period. There is limited experience, however, with an
`infusion of 500mg, diluted in 250mL of 0.9% Sodium Chloride over 3.5 to 4 hours on days 1 &
`14; hypotension occurred in 2 of the 30 patients administered that dose in the clinical trial.
`
`To learn more about the use of Venofer® in CKD or to obtain a copy of the full prescribing
`information, please contact American Regent, Inc. at 800-645-1706.
`
`
`Venofer® is manufactured under license from Vifor (International) Inc., Switzerland
`
`
`View Full Prescribing Information
`
`
`Pharmacosmos, Exh. 1058, p. 2

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket